Standard Chartered to Sell East African Headquarters as Footprint Shrinks Bloomberg · Markets 32m ago
Mirum Pharma's Phase 2b Study Of Volixibat For Sclerosing Cholangitis Meets End Point, Shares Gain NASDAQ · Markets 41m ago